CoChat

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy

Saoudi, Amel, Zarrouki, Faouzi, Sebrié, Catherine, Izabelle, Charlotte, Goyenvalle, Aurélie, Vaillend, Cyrille · 2021 · Disease Models & Mechanisms
Cited by 40

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The exon-52-deleted mdx52 mouse is a critical model of Duchenne muscular dystrophy (DMD), as it features a deletion in a hotspot region of the DMD gene, frequently mutated in patients. Deletion of exon 52 impedes expression of several brain dystrophins (Dp427, Dp260 and Dp140), thus providing a key model for studying the cognitive impairment associated with DMD and testing rescuing strategies. Here, using in vivo magnetic resonance imaging and neurohistology, we found no gross brain abnormalities in mdx52 mice, suggesting that the neural dysfunctions in this model are likely at the level of brain cellular functionalities. Then, we investigated emotional behavior and fear learning performance of mdx52 mice compared to mdx mice that only lack Dp427 to focus on behavioral phenotypes that could be used in future comparative preclinical studies. mdx52 mice displayed enhanced anxiety and a severe impairment in learning an amygdala-dependent Pavlovian association. These replicable behavioral outcome measures are reminiscent of the internalizing problems reported in a quarter of DMD patients, and will be useful for preclinical estimation of the efficacy of treatments targeting brain dysfunctions in DMD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dmm.049028

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 65

  1. Anderson, 2002, Brain function in Duchenne muscular dystrophy, Brain J. Neurol., 125, 4, 10.1093/brain/awf012 · DOI · Paper page
  2. Aoki, 2010, In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse, Mol. Ther., 18, 1995, 10.1038/mt.2010.186 · DOI
  3. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  4. Aranmolate, 2017, Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy, BMC Neurosci., 18, 63, 10.1186/s12868-017-0381-0 · DOI
  5. Aupy, 2020, Long-term efficacy of AAV9-U7snRNA-mediated exon 51 skipping in mdx52 mice, Mol. Ther. Methods Clin. Dev., 17, 1037, 10.1016/j.omtm.2020.04.025 · DOI · Paper page
  6. Bagdatlioglu, 2020, Cognitive impairment appears progressive in the mdx mouse, Neuromuscul. Disord. NMD, 30, 368, 10.1016/j.nmd.2020.02.018 · DOI · Paper page
  7. Beastrom, 2011, mdx(5cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx mice, Am. J. Pathol., 179, 2464, 10.1016/j.ajpath.2011.07.009 · DOI · Paper page
  8. Belmaati Cherkaoui, 2020, Dp71 contribution to the molecular scaffold anchoring aquaporine-4 channels in brain macroglial cells, Glia, 69, 954, 10.1002/glia.23941 · DOI
  9. Benabdesselam, 2012, Dp71 gene disruption alters the composition of the dystrophin-associated protein complex and neuronal nitric oxide synthase expression in the hypothalamic supraoptic and paraventricular nuclei, J. Endocrinol., 213, 239, 10.1530/JOE-12-0066 · DOI
  10. Beroud, 2007, Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy, Hum. Mutat., 28, 196, 10.1002/humu.20428 · DOI · Paper page
  11. Caudal, 2020, Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model, PLoS ONE, 15, e0230083, 10.1371/journal.pone.0230083 · DOI · Paper page
  12. Chaussenot, 2019, Dp71-dystrophin deficiency alters prefrontal cortex excitation-inhibition balance and executive functions, Mol. Neurobiol., 56, 2670, 10.1007/s12035-018-1259-6 · DOI · Paper page
  13. Chaussenot, 2015, Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes, Neurobiol. Learn. Mem., 124, 111, 10.1016/j.nlm.2015.07.006 · DOI · Paper page
  14. Colombo, 2017, Assessing mental health in boys with Duchenne muscular dystrophy: Emotional, behavioural and neurodevelopmental profile in an Italian clinical sample, Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc., 21, 639, 10.1016/j.ejpn.2017.02.007 · DOI · Paper page
  15. Culligan, 2001, Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy, BMC Cell Biol., 2, 2, 10.1186/1471-2121-2-2 · DOI
  16. Dallérac, 2011, Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse, Neurobiol. Dis., 43, 635, 10.1016/j.nbd.2011.05.012 · DOI · Paper page
  17. Daoud, 2009, Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression, Hum. Mol. Genet., 18, 3779, 10.1093/hmg/ddp320 · DOI
  18. Daoud, 2009, Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS ONE, 4, e6574, 10.1371/journal.pone.0006574 · DOI · Paper page
  19. Doorenweerd, 2017, Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy, Sci. Rep., 7, 12575, 10.1038/s41598-017-12981-5 · DOI · Paper page
  20. Doorenweerd, 2014, Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy, Ann. Neurol., 76, 403, 10.1002/ana.24222 · DOI · Paper page
  21. Felisari, 2000, Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy, Neurology, 55, 559, 10.1212/WNL.55.4.559 · DOI
  22. Frésard, 2012, Fine mapping of complex traits in non-model species: using next generation sequencing and advanced intercross lines in Japanese quail, BMC Genomics, 13, 551, 10.1186/1471-2164-13-551 · DOI
  23. Fritschy, 2012, Molecular and functional heterogeneity of GABAergic synapses, Cell. Mol. Life Sci. CMLS, 69, 2485, 10.1007/s00018-012-0926-4 · DOI
  24. Goyenvalle, 2015, Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers, Nat. Med., 21, 270, 10.1038/nm.3765 · DOI · Paper page
  25. Guimaraes, 2020, Imaging phenotype correlation with molecular and molecular pathway defects in malformations of cortical development, Pediatr. Radiol., 50, 1974, 10.1007/s00247-020-04674-5 · DOI
  26. Helleringer, 2018, Cerebellar synapse properties and cerebellum-dependent motor and non-motor performance in Dp71-null mice, Dis. Model. Mech., 11, dmm033258, 10.1242/dmm.033258 · DOI · Paper page
  27. Hildyard, 2020, Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo, Wellcome Open Res., 5, 76, 10.12688/wellcomeopenres.15762.1 · DOI
  28. Hinton, 2009, Association of autistic spectrum disorders with dystrophinopathies, Pediatr. Neurol., 41, 339, 10.1016/j.pediatrneurol.2009.05.011 · DOI
  29. Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 · DOI · Paper page
  30. Jamniczky, 2011, Modularity in the skull and cranial vasculature of laboratory mice: implications for the evolution of complex phenotypes, Evol. Dev., 13, 28, 10.1111/j.1525-142X.2010.00453.x · DOI
  31. Kameya, 1997, Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina, Hum. Mol. Genet., 6, 2195, 10.1093/hmg/6.13.2195 · DOI
  32. Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur. J. Neurosci., 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
  33. Kogelman, 2018, Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy, PLoS ONE, 13, e0194636, 10.1371/journal.pone.0194636 · DOI
  34. Lee, 2002, Altered regional brain glucose metabolism in Duchenne muscular dystrophy: a pet study, Muscle Nerve, 26, 506, 10.1002/mus.10238 · DOI · Paper page
  35. Lidov, 1995, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Hum. Mol. Genet., 4, 329, 10.1093/hmg/4.3.329 · DOI · Paper page
  36. Lorusso, 2013, Specific profiles of neurocognitive and reading functions in a sample of 42 Italian boys with Duchenne Muscular Dystrophy, Child Neuropsychol. J. Norm. Abnorm. Dev. Child. Adolesc., 19, 350, 10.1080/09297049.2012.660912 · DOI
  37. Ma, 2005, A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy, Neuroscience, 135, 1203, 10.1016/j.neuroscience.2005.07.014 · DOI · Paper page
  38. Manning, 2014, Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy, Exp. Physiol., 99, 1370, 10.1113/expphysiol.2014.079475 · DOI
  39. Miranda, 2009, Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice, Cereb. Cortex N. Y. N., 19, 876, 10.1093/cercor/bhn135 · DOI · Paper page
  40. Mori, 2015, Gene expression profiles in Rana pirica tadpoles following exposure to a predation threat, BMC Genomics, 16, 258, 10.1186/s12864-015-1389-4 · DOI
  41. Morris, 1995, Apo-dystrophins (Dp140 and Dp71) and dystrophin splicing isoforms in developing brain, Biochem. Biophys. Res. Commun., 215, 361, 10.1006/bbrc.1995.2474 · DOI
  42. Mortazavi, 2021, Polymorphic SNPs, short tandem repeats and structural variants are responsible for differential gene expression across C57BL/6 and C57BL/10 substrains, bioRxiv, 2020.03.16.993683
  43. Nonneman, 2012, A defect in dystrophin causes a novel porcine stress syndrome, BMC Genomics, 13, 233, 10.1186/1471-2164-13-233 · DOI
  44. Paprocka, 2021, Congenital disorders of glycosylation from a neurological perspective, Brain Sci., 11, 88, 10.3390/brainsci11010088 · DOI
  45. Paxinos, 2001, The Mouse Brain in Stereotaxic Coordinates, Compact
  46. Paylor, 2001, Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization, Physiol. Behav., 73, 781, 10.1016/S0031-9384(01)00515-7 · DOI
  47. Phillips, 1992, Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning, Behav. Neurosci., 106, 274, 10.1037/0735-7044.106.2.274 · DOI · Paper page
  48. Poysky, 2007, Neuromuscul. Disord., 17, 986, 10.1016/j.nmd.2007.06.465 · DOI · Paper page
  49. Razzoli, 2020, Social stress is lethal in the mdx model of Duchenne muscular dystrophy, EBioMedicine, 55, 102700, 10.1016/j.ebiom.2020.102700 · DOI · Paper page
  50. Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev. Med. Child Neurol., 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
  51. Romo-Yáñez, 2020, Characterization of the expression of dystrophins and dystrophin-associated proteins during embryonic neural stem/progenitor cell differentiation, Neurosci. Lett., 736, 135247, 10.1016/j.neulet.2020.135247 · doi:10.1016/j.neulet.2020.135247
  52. Sarig, 1999, Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development, Hum. Mol. Genet., 8, 1, 10.1093/hmg/8.1.1 · DOI
  53. Satz, 2010, Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain, J. Neurosci., 30, 14560, 10.1523/JNEUROSCI.3247-10.2010 · DOI · Paper page
  54. Sebrié, 2008, Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21, Anat. Rec. Hoboken NJ, 2007, 254, 10.1002/ar.20640 · DOI
  55. Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
  56. Septien, 1991, [Mental development in Duchenne muscular dystrophy. Correlation of data of the brain scanner], Pediatrie, 46, 817
  57. Snow, 2013, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci. Biobehav. Rev., 37, 743, 10.1016/j.neubiorev.2013.03.016 · DOI · Paper page
  58. Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS ONE, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
  59. Vaillend, 1998, Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products, Neuroscience, 86, 53, 10.1016/S0306-4522(98)00023-2 · DOI · Paper page
  60. Vaillend, 2017, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum. Mol. Genet., 26, 1041
  61. Vaillend, 2010, Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse, Mol. Ther., 18, 1683, 10.1038/mt.2010.134 · DOI · Paper page
  62. Vaillend, 2008, Genes, plasticity and mental retardation, Behav. Brain Res., 192, 88, 10.1016/j.bbr.2008.01.009 · DOI
  63. Vaillend, 1999, Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins, Neuromuscul. Disord., 9, 296, 10.1016/S0960-8966(99)00029-2 · DOI · Paper page
  64. Wallace, 2001, Neurotoxic lesions of the lateral nucleus of the amygdala decrease conditioned fear but not unconditioned fear of a predator odor: comparison with electrolytic lesions, J. Neurosci., 21, 3619, 10.1523/JNEUROSCI.21-10-03619.2001 · DOI · Paper page
  65. Young, 2008, Cognitive and psychological profile of males with Becker muscular dystrophy, J. Child Neurol., 23, 155, 10.1177/0883073807307975 · DOI

Cited by

Metadata

Authors
Saoudi, A., Zarrouki, F., Sebrié, C., Izabelle, C., Goyenvalle, A., & Vaillend, C.
Affiliations
  • Université Paris-Saclay, CNRS, Institut des Neurosciences Paris Saclay 1 , 91190, Gif-sur-Yvette , France
  • Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Service Hospitalier Frédéric Joliot, 4 place du général Leclerc 3 , 91401 Orsay , France
  • Université Paris-Saclay, UVSQ, Inserm, END-ICAP 2 , 78000 Versailles , France
Venue
Disease Models & Mechanisms
Published
2021-09-01
Volume
14
Issue
9
ISSN
  • 1754-8403
  • 1754-8411
Cited by
40
References
7
Language
en
Funders
  • Centre National de la Recherche Scientifique
  • Université Paris-Saclay
  • Association Monégasque contre les Myopathies
  • Ministère de l'Enseignement Supérieur et de la Recherche
  • Horizon 2020 Framework Programme (847826)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.